Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04277208 · ClinicalTrials.gov registry record

Opioid-Free Study in Arthroscopic Rotator Cuff Repair

A clinical trial of Rotator Cuff Tears, sponsored by Rothman Institute Orthopaedics.

Completed
Registry status
36
Enrollment target
1
Study location

NCT04277208: Completed study of Rotator Cuff Tears, sponsored by Rothman Institute Orthopaedics.

NCT04277208 is a study of Rotator Cuff Tears that has completed, run by Rothman Institute Orthopaedics. The registered enrollment target is 36 participants, below the 1,279-participant average among 20 other Rotator Cuff Tears trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04277208, a study of Rotator Cuff Tears, has completed, sponsored by Rothman Institute Orthopaedics.

COMPLETED
Registry status
36 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to develop and test an opioid-free pain control protocol for patients undergoing arthroscopic rotator cuff repair.

Primary Outcome

data collected to the time from surgery until the patient chooses to fulfill a prescription for opioid medication following surgery

Conditions Studied

Study Locations (1)

Pennsylvania

  • Rothman Institute - Philadelphia

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2018-06-13
Est. Completion 2019-07-01
Rothman Institute Orthopaedics

23 total trials

What the finished NCT04277208 record still lists

NCT04277208 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 1,279-participant average among 20 other Rotator Cuff Tears trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Rotator Cuff Tears appearing as the primary indexed condition, and to 0 interventions.

NCT04277208 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04277208 about?

NCT04277208 is a clinical study titled "Opioid-Free Study in Arthroscopic Rotator Cuff Repair". The purpose of this study is to develop and test an opioid-free pain control protocol for patients undergoing arthroscopic rotator cuff repair.

What is the current status of trial NCT04277208?

This trial is currently completed. The enrollment target is 36 participants. The study started on 2018-06-13. Estimated completion is 2019-07-01.

What conditions does trial NCT04277208 study?

This clinical trial studies the following conditions: Rotator Cuff Tears.

Who is sponsoring clinical trial NCT04277208?

This trial is sponsored by Rothman Institute Orthopaedics, which has 23 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04277208 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rotator Cuff Tears

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04277208's enrollment target sits among peer trials

36 19th of 20 higher than 2 of 20 other Rotator Cuff Tears trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Rotator Cuff Tears trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00929006 · 36 participants · Early Phase 1

    Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

  • NCT01891318 · 36 participants · Phase 1

    Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

  • NCT02291848 · 36 participants · Phase 1

    Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

  • NCT02366819 · 36 participants · Phase 4

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04277208, the US trial registry maintained by the National Library of Medicine. NCT04277208 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.